发布: 2019年09月05日第9卷第17期 DOI: 10.21769/BioProtoc.3349 浏览次数: 4103
评审: Alexandros AlexandratosAlexander GalkinAnonymous reviewer(s)
Abstract
The architecture of quinone/inhibitor-access channel in proton-translocating NADH-quinone oxidoreductase (respiratory complex I) was modeled by X-ray crystallography and cryo-EM, however, it remains debatable whether the channel model reflects the physiologically relevant state present throughout the catalytic cycle. Using photoreactive [125I]amilorides, we demonstrated that amiloride-type inhibitors bind to the interfacial region of multiple subunits (49-kDa, ND1, PSST, and 39-kDa subunits), which is difficult to reconcile with the current channel model. This report describes the procedures for photoaffinity labeling of bovine submitochondrial particles by photoreactive [125I]amilorides. The protocol could be widely applicable for the characterization of various biologically active compounds, whose target protein remains to be identified or characterized.
Keywords: Photoaffinity labeling (光亲和标记)Background
Proton-translocating NADH-quinone oxidoreductase (respiratory complex I) is a multi-subunit membrane protein complex, which catalyzes the initial step of mitochondrial/bacterial electron transport chains (Hirst, 2013). The recent progress in X-ray crystallography and cryo-EM enabled modeling the entire structure of complex I. The structural studies proposed the quinone/inhibitor-access channel model to explain how quinone/inhibitor bind to the enzyme (Sazanov, 2015; Wirth et al., 2016). However, since there is currently no structural data of complex I with bound-quinone or inhibitor, it remains debatable whether the channel model reflects the physiologically relevant state present throughout the catalytic cycle.
Photoaffinity labeling technique, which uses a synthetic ligand that possesses photoreactive group such as diazirine and phenyl-azido, is the most commonly used method of affinity-based protein modification (Hatanaka and Sadakane, 2002). It provides a powerful means of investigating interactions between biologically active compounds and the proteins of interest. Recently, to get insights into the structure of quinone/inhibitor-binding site in mitochondrial complex I, we carried out photoaffinity labeling using photoreactive [125I]amilorides ([125I]PRA3, [125I]PRA4, [125I]PRA5, and [125I]PRA6) with bovine heart submitochondrial particles (SMPs) (Uno et al., 2019). The radioisotope (125I) was used as a tracer, which enables the experiment with the lowest concentrations of ligands (1-10 nM). These concentrations are approximately two orders of magnitude lower than those of alkyne-tagged amilorides (PRA1 and PRA2, Murai et al., 2015), which can be conjugated with biotin or fluorophores via Cu+-catalyzed click chemistry (Wang et al., 2003) after cross-linking reaction. This advantage may minimize the possibility of non-specific labeling, which is a primary cause of false-positive results.
We herein describe the detailed procedures of the photoaffinity labeling of complex I in bovine SMPs by [125I]PRA5 as an example (Figure 1), which includes 1) preparation of 125I-tagged photoreactive ligand, 2) cross-linking of bovine SMPs by the ligand, and 3) identification of the labeled protein(s).
Figure 1. Schematic presentation of photoaffinity labeling of bovine heart SMPs by [125I]amilorides
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
分类
生物化学 > 其它化合物 > 小分子药物
生物化学 > 蛋白质 > 标记
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link